Search Bar & Filters
Found 11 Actively Recruiting clinical trials
Actively Recruiting
Researchers are evaluating two current approaches to address social needs among adults with multiple chronic conditions. This randomized clinical trial compares higher intensity telephonic navigation against lower intensity virtual outreach to see which strategy better helps patients access social services, meet social needs, and close clinical care gaps. The study also explores how different patient groups may respond to these interventions and investigates the pathways linking social support to improved health outcomes. Participants will be assigned to one of two groups the higher intensity arm involves active telephonic outreach from a health navigator with follow-up contacts for up to three months, while the lower intensity arm consists of outreach via text, email, or letter providing information about available governmental benefits and services. The trial includes qualitative assessments through patient focus groups and navigator interviews to understand the impact and mechanisms of each intervention. During the study, participants will be monitored for receipt of social services and reduction in social needs approximately six months after enrollment, as well as clinical care gap closure around 12 months. Outcomes will be assessed through patient reports and health records. The study plans to provide evidence to guide healthcare systems on effective strategies to support patients with multiple chronic conditions by addressing their social needs over time.
Actively Recruiting
Researchers are evaluating whether managing heart failure patients using the CardioMEMS HF System, which monitors pulmonary artery PA pressure, improves long-term health outcomes compared to usual care without PA pressure monitoring. This observational study focuses on heart failure patients and aims to determine the impact on hospitalization rates and survival over two years in a real-world setting. Abbott Medical Devices leads this research to better understand the benefits of PA pressure-guided management. Participants include heart failure patients either implanted with the CardioMEMS PA pressure sensor or managed without PA pressure monitoring as a control group. The study compares two groups those with the device and those without it. The CardioMEMS HF System continuously monitors PA pressure to guide heart failure management decisions. During the study, researchers will track heart failure hospitalizations and overall survival for two years. They will review hospitalization rates related to heart failure and survival from any cause to assess differences between the groups. Participants will be monitored regularly, and their health outcomes will be recorded to evaluate the effectiveness of PA pressure-guided management over standard care.
Actively Recruiting
Adolescent alcohol and other drug use is a major public health problem that leads to serious health, social, and economic consequences for young people. Early identification and intervention are crucial to improving outcomes. This study evaluates whether a centralized, virtually delivered version of Screening, Brief Intervention and Referral to Treatment SBIRT can be implemented cost-effectively in pediatric primary care to better identify and treat adolescents at high or severe risk of substance use and related mental health problems. It compares this virtual model to the traditional in-person SBIRT approach in a large, diverse health system. The trial involves two groups of pediatric primary care clinics one where behavioral health clinicians provide brief interventions in person by appointment Traditional SBIRT, and another where interventions are delivered virtually by video or telephone through a centralized behavioral health clinician Centralized Virtual SBIRT. This approach aims to overcome barriers like lack of trained staff and time constraints in busy clinics. Both methods focus on adolescents aged 12 to 17 identified as at risk during routine Well Visits. Participants will be monitored over a two-year intervention period. Researchers will track referrals to behavioral health clinicians, brief interventions delivered, initiation and engagement in specialty treatment, diagnoses related to substance use and mental health, substance use behaviors, depressive symptoms, suicidality, and health services utilization. These assessments occur at 1- and 2-year follow-ups, with specialty treatment monitored within specific timeframes after screening. The study seeks to understand which SBIRT delivery method best supports early intervention and care for adolescent substance use and mental health issues.
Actively Recruiting
Researchers are evaluating the clinical performance and user experience of Paragon CRT orthokeratology contact lenses with a 5mm optic zone diameter in people with myopia and astigmatism. This prospective, multi-site clinical study focuses on the first-fit success, visual performance, and eye health outcomes of these lenses when fit empirically. The study includes participants aged 6 to 35 years who meet specific vision and eye health criteria. Participants will wear the Paragon CRT orthokeratology lenses daily for approximately 5 minutes each day, with a recommended nightly wear schedule of about 8 hours while sleeping. The study assesses comfort at 5 minutes and 1 month after the final lens fitting. The lenses are designed to be worn overnight, with ongoing monitoring of fit and vision during scheduled visits. During the study, participants will undergo various assessments including vision tests, eye health evaluations, and comfort ratings shortly after lens insertion and after one month of use. Researchers will monitor eye condition, visual acuity, and compliance with the wear and visit schedules. The total study duration extends up to 4 months, with visits to check lens fit, eye health, and user experience to ensure safety and effectiveness of the lenses.
Actively Recruiting
Researchers are evaluating a new approach to prevent severe low blood sugar hypoglycemia in adults with type 2 diabetes who are at high risk for this condition. Hypoglycemia can cause serious health problems including falls, heart issues, and memory loss, yet it is often not well managed. The study aims to test whether a clinical pharmacist, called a Hypoglycemia Champion, using a clear guideline named Hypoglycemia on a Page HOAP can improve the safety of diabetes treatment compared to usual care. Participants are divided into two groups. One group receives proactive outreach and support from the clinical pharmacist applying the HOAP guidelines to manage and reduce hypoglycemia risk. The other group receives standard diabetes care after the HOAP guideline is shared system-wide. The pharmacist contacts patients mainly by phone and electronic messaging to provide personalized care and adjust treatments. All medical decisions remain with each patients regular healthcare team. During the study, participants will have their diabetes medication use, particularly the discontinuation of certain drugs that increase hypoglycemia risk, monitored over six months. Researchers will also track the use of continuous glucose monitors CGM, prescriptions for glucagon, blood sugar control, and hospital visits due to hypoglycemia. The study includes assessments at multiple time points up to one year to evaluate safety, treatment changes, and health outcomes, aiming to improve patient safety and reduce healthcare costs.
Actively Recruiting
This research aims to compare two treatment strategies for patients with uncomplicated type B aortic dissection, a serious condition affecting the aorta. The study evaluates whether an initial invasive approach using thoracic endovascular aortic repair TEVAR plus medical therapy reduces death or major aortic problems better than a conservative strategy of medical therapy with monitoring. The trial is a prospective, randomized clinical trial enrolling adults within 48 hours to 6 weeks after their initial hospital admission for this condition. Participants are randomly assigned to one of two groups one receives the TEVAR procedure using a customized stent-graft implanted with imaging guidance, alongside medical therapy the other group undergoes medical therapy alone with recommended blood pressure and cardiovascular risk management. The study allows aortic interventions only as specified by the protocol, while other care is managed by usual clinical teams. Follow-up includes centralized record review and remote blood pressure monitoring, with median follow-up planned for about 4 years. During the study, participants will be monitored through medical records and phone contacts, including assessments of quality of life and cardiovascular events. Researchers will measure outcomes such as all-cause death, major aortic complications, and hospitalizations over the follow-up period. Safety, quality of care, and cardiovascular events, including strokes and other complications, will be closely tracked. Participation may last several years with ongoing observation to evaluate long-term effects of the treatment strategies.
Actively Recruiting
Researchers are studying adults with heart failure and iron deficiency to see if reminding doctors about treatment guidelines for iron deficiency affects the use of intravenous IV iron during hospital stays. The study compares two groups of hospitalized patients those whose doctors receive notifications about their iron test results and guidelines, and those whose doctors do not receive such notifications. This trial aims to understand if these reminders change how often IV iron is used and if increased use improves health outcomes like fewer hospital visits and lower mortality. The study involves up to 21 medical centers randomly assigned to either an intervention or control group. In the intervention group, doctors receive a one-time notification with their patients iron test results, information about current guidelines, and details about IV iron options and dosages. Doctors in the control group continue usual care without receiving these notifications. The study team does not interact directly with patients or make clinical decisions care remains with each patients doctor. Participants are adults hospitalized for any reason with diagnosed heart failure, low ejection fraction, and iron deficiency. Researchers will track whether patients receive IV iron within 7 days of hospital admission and follow health outcomes such as death and heart failure-related hospitalizations for up to 12 months. Data analysis will assess how provider notifications impact treatment use and patient outcomes, with additional monitoring of outpatient visits, emergency visits, and hospitalizations.
Actively Recruiting
Researchers are studying Medicare beneficiaries with Lumbar Spinal Stenosis LSS and Neurogenic Claudication NC to compare outcomes after two different procedures MILD Percutaneous Image-Guided Lumbar Decompression and Interspinous Process Decompression IPD. This observational study tracks patients treated since January 1, 2017, evaluating the rates of surgical and minimally invasive interventions as well as any harms related to these procedures over 24 months. The study uses Medicare claims data and does not require prior patient consent or IRB oversight. The study includes two groups of patients those who received the MILD procedure, involving partial decompression under image guidance by removing tissue and bone at the affected spinal level, and those who underwent IPD, a device-based decompression technique. Both groups are observed through Medicare data for two years after their initial procedure to assess the need for further surgeries or interventions and to monitor for any complications. Participants are followed for 24 months after their index procedure using Medicare claims data. Researchers monitor the rates of harms associated with the initial treatment and the frequency of additional surgical or minimally invasive interventions. Since this is an observational study, data collection relies on existing Medicare records without direct patient involvement, and the study will continue enrolling patients until the sponsor stops it.
Actively Recruiting
This research aims to evaluate an investigational noninvasive neuromodulation device for treating Restless Legs Syndrome RLS. The study focuses on assessing how well participants tolerate the device, its safety, and its effects on RLS symptoms, including the number of awakenings related to RLS during the night. The device has been designated as non-significant risk by the institutional review board IRB. The study lasts 12 weeks, beginning with a 1-week baseline period without intervention, followed by 1 week of Tonic Motor Activation TOMAC therapy involving 30-minute stimulation sessions. After this, participants undergo 4 weeks of Extended Duration XD- TOMAC therapy nightly. In the final 6 weeks, participants use the investigational device with different therapy settings in a pseudo-randomized order across three 2-week periods to assess varying stimulation waveforms. During the study, participants set up and use the device at bedtime as instructed. Researchers monitor sleep quality and RLS symptoms through various measures, including nightly awakenings, symptom severity scales, sleep efficiency, and patient-reported improvement. Participants complete electronic questionnaires and communicate with the study staff remotely throughout the home-based study. The primary measure is the number of RLS-related awakenings over 12 weeks, with secondary measures assessing symptom changes and sleep quality.
Actively Recruiting
Healthy Volunteer
Researchers are exploring how multi-cancer detection MCD tests might work as tools to screen for multiple cancers at once in adults aged 45 to 75 without cancer. The study aims to understand the performance of two different MCD tests compared to a control group and how patients and doctors handle both normal and abnormal test results. This feasibility study will inform future trials and help improve early cancer detection when treatment is most effective. Participants will be randomly assigned to one of three groups one group will undergo the Shield MCD test, another the Avantect MCD test, and the third will serve as a control group with blood collection only. Blood samples are collected at enrollment and again after one year. Participants at unblinded sites receive their test results, and those with abnormal findings follow up with their clinicians for further testing. After the active study period, participants are followed passively for up to 10 years. During the study, participants complete questionnaires and provide blood samples on schedule. Researchers collect medical record data and monitor participant adherence, diagnostic outcomes, anxiety related to testing, and the accuracy of the tests in predicting cancer origins. Primary outcomes include enrollment feasibility, questionnaire completion, blood sample provision, and follow-up retention. Secondary outcomes evaluate diagnostic resolution, complications, and psychological impact. This comprehensive approach helps assess the practical aspects of MCD testing and its potential role in cancer screening.
1-10 of 11
1